InsidersTradesSigma
Track the 健之佳 stock price and the full management transaction log of the company, a listed equity based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 健之佳 has recorded 13 insider filings. Market capitalisation: €2.4bn. The latest transaction was reported on 25 September 2025 (Purchase). Among the most active insiders: 蓝心悦. All data is openly available.
13
Insider Decl.
n/a
Thresholds
€452,554
13 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,189 of 29,064 companies
62.4
score / 100
Value85
Quality40
FCF yld42%
Earn yld6.1%
EV/EBITDA5.9x
ROE5.5%
Gross mgn36%
Net mgn1.7%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 September 2025
Declarations13 total
13 of 13 declarations
Acerca de 健之佳
健之佳 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XSHG. Se centra en el desarrollo y la distribución de productos farmacéuticos y sanitarios.